Skip to main content

Table 1 Colon cancer patient characteristics

From: Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer

Characteristic

Patients (n = 93)

Frequency (%)

Gender

  

 Male

58

62.4

 Female

35

37.6

Age (years)

  

 ≤ 65

24

25.8

 > 65

69

74.2

Tumor site

  

 Right colon

31

33.3

 Transverse colon

8

8.6

 Descending colon

13

14

 Sigmoid colon

40

43

 Synchronous tumors

1

1.1

Colonoscopy biopsy

  

 Adenocarcinoma

76

81.7

 Polyp

17

18.3

TNM postoperative stage (pTNM)

  

 Less aggressive (polyp, stages 0, I, and II)

56

60.2

 More aggressive (stages III and IV)

37

39.8

Adjuvant treatment (XELOX, oxaliplatin-capecitabine)

  

 Yes

42

45.2

 No

51

54.8

Metastasis

  

 Yes

21

22.6

  Synchronous

12

12.9

  Metachronous

9

9.7

 No

72

77.4

Metastasis location

  

 Liver

14

15.1

 Lung

2

2.1

 Ganglion

1

1.1

 Other locations

4

4.3

Survival (at the end of study)

  

 Alive

88

94.6

 Died

5

5.4

  1. pTNM pathological classification of tumor-node-metastasis system according to 2017 last edition